5-Bromo-2-fluoro-1-(1,1,2,2,2-pentafluoroethyl)-benzene, 98.0%, 1g

5-(t-Butyldimethylsilyloxy)-2-methoxyphenylboronic acid, 98%, 250mg

1-(2-CHLOROTHIAZOL-5-YL)ETHANONE, 95.0%, 10g

Bis[3,5-dibromo-4-(2-hydroxyethoxy)phenyl] sulfone, 97%, 500g

Methacryloxypropylmethyldimethoxysilane (inhibited with MEHQ), 95%, 25g

Objectif IOS plan PL-M 20x/0.40 corrigé à l'infini. Distance de travail 7,8 mm. Pas de correction du verre de protection

2-(4-(tert-Butyl)phenyl)pyridin-3-amine, 95%, 250mg

2-(aminomethyl)-1,2,3,4-tetrahydronaphthalen-2-ol, 95.0%, 500mg

4-(p-Tolyl)butanoic acid, 97.0%, 10g

5,7-DIMETHOXYQUINAZOLIN-4(3H)-ONE, 97.0%, 1g

4-(2-chloroisonicotinoyl)morpholine, 95.0%, 5g

Aprotinine, 500 mg

4,4'-Methylenebis(2-methylphenol), 95.0%, 5g